IRP Vaccine Research Stretches Back to the NIH’s Birth
By Michele Lyons
Monday, May 18, 2020
Over the past few months, the world has gained a new appreciation for the long, difficult process of producing vaccines as it waits anxiously for one that will provide protection from the novel coronavirus. With the NIH Vaccine Research Center’s efforts to develop a COVID19 vaccine drawing a huge amount of media attention, it is easy to forget that the IRP has been making vital contributions to vaccine development for more than 100 years. These efforts have helped produce vaccinations for smallpox, rubella, hepatitis A, whooping cough, human papillomavirus (HPV), and several other diseases. Read on for a visual journey through the history of IRP vaccine research.
By IRP Staff Blogger
Monday, October 24, 2016
This year, members of the National Academy of Medicine elected four NIH Intramural researchers to their ranks, one of the highest honors in science. Learn a bit about each of their research and follow the links to their IRP profiles for more information.
By IRP Staff Blogger
Wednesday, January 21, 2015
Long recognized as essential to global health, vaccines protect individuals and populations from contagion and the reappearance of eradicated diseases. Vaccination against deadly diseases prevents two to three million deaths worldwide every year, and there are significant economic benefits as well. In the United States, every dollar spent on the routine childhood immunization program saves society more than $16 in future costs.
